Font Size:
a
A
A
Keyword [Thrombin Activatable]
Result: 1 - 20 | Page: 1 of 2
1.
Effects Of Homocysteine On Vascular Endothelial Cells: Induction Of Apoptosis, Regulation Of TAFI And TFPI Expression, And Proteomic Alteration
2.
Effects Of Thrombin-activable Fibrinolysis Inhibitor And Hirudin On Fibrinolysis
3.
Study On Molecular Mechanisms Of Glanzmann Thrombasthenia And Antithrombotic Mechanisms Of Holothurian Glycosaminoglycan Extracted From Sea Cucumber
4.
Changes Of Plasma Thrombin-Activatable Fibrinolysis Inhibitor In The Senile With Unstable Angina Pectoris And The Influence Of Low-Molecular-Weight Heparin
5.
Studies On The Thrombin Activatable Fibrinolysis Inhibitor Of Coronary Atherosclerotic Heart Disease
6.
Investigation Of TAFI Level And Mechanism Of Action In The Process Of Atherosclerosis In Rats.
7.
Low Molecular Weight Heparin On Coagulation And Fibrinolysis System Of Patients With Acute Coronary Syndrome: Clinical Study Of Its Effects, Avalability
8.
A Study Of Relation Between Thrombin Activatable Fi Brinolysis Inhibition And Coronary Heart Disease.
9.
Effect Of Baicalin On Atherosclerosis And TAFI Level In Rabbits
10.
Study On The Association Of The Gene Polymorphism Of Thrombin Activatable Fibrinolysis Inhibitor With Coronary Atherosclerotic Heart Disease
11.
Correlation Of Metablic Parameters Of Non-Obesity Type 2 Diabetic Patients To Functions Of TAFI, PAI-1 And VWF
12.
Study Of The Relativity Between Thrombin-activatable Fibrinolysis Inhibtor And Stroke
13.
Study On The The Association Of Genetic Variations In Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Encoding Region And The Risk Of Type 2 Diabetes Mellitus
14.
Effects Of CPB2 Gene Silencing On TAFI Expression And Metastatic In The Breast Cancer Cells
15.
The Study On The Relationship Between Cruor-fibrinolysis System And The HuiZhuoTanZu Syndrome Of Coronary Heart Disease
16.
The Expression Of TAFI In The Patient With Polycystic Ovary Syndrome
17.
Association Between Thrombin Activatable Fibrrinolysis Inhibitor And Breast Cancer
18.
Study On The Thrombin-activatable Fibrinolysis Inhibitor In Venous Thrombolism
19.
Expression Of TAFI In Cervical Squamous Cell Carcinoma Tissues With And Without Pelvic Lymph Node Metastasis And Its Clinical Significance
20.
The Relationship Between Thrombin Activatable Fibrinolysis Inhibitor And Stroke: A Case-control Study
<<First
<Prev
Next>
Last>>
Jump to